• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Research and Markets: Key Insights into Russia's Pharmaceutical Market

Posted on: Friday, 8 July 2005, 12:00 CDT

Research and Markets (http://www.researchandmarkets.com/reports/c20499) has announced the addition of Russia's Current Pharmaceutical Market Demand: Information View to their offering.

These reports contain up-to-date quantitative estimates of the market demand enabling you to characterize exhaustively the situation in the Russian pharmaceutical market (RPM) and forecast changes in the market tendencies.

The source of the information is the search traffic data of the site www.rlsnet.ru -- the corporate site of "RLS -- Russian Drug Directory" -- Russia's leading publisher of medical directories (annual circulation -- over 350 000 copies). The site provides free web-access to a data base containing complete information about all medicines present on the Russian pharmaceutical market (over 20 000 search queries on medicines daily). The analysis of search queries allows us to calculate the index of the drug's information demand which are titled "Vishkovsky index, Iv" (for each of the 4500 brands on RPM). Iv has a strong correlation with sales indicators and (most important) anticipates the sales indicators.

The unique aspects of these reports are actuality and complete RPM scope.

Usage of the IID information provides:

-- Market state monitoring;

-- Sales forecast;

-- Effective control of the large advertising campaigns;

-- Monitoring of competitor's marketing effectiveness.

Market analysis based on the data of this report permits you to solve key marketing tasks -- the forecasting of sale's tendencies changes and the proper time correction of the trade activity avoiding painful losses due to the negative market fluctuations.

Each report contains

-- TOP-100 drug Iv-rating;

-- 100 last 6 month Iv graphs (for each medicine of TOP-100 rating);

-- TOP-50 Iv-rating of main RPM players.

The target audience for this quarterly report includes top-managers who control the trade activity on the Russian pharmaceutical market (RPM) or are involved in planning of the development strategies for the RPM.

The author of this report's basic methodology is Gennady L. Vishkovsky -- PhD, member of the International Academy of Informatization and RLS Editor-in-Chief who has worked on the RPM since it's appearance in 90-s.

Companies mentioned:

-- Abbott Laboratories

-- Actavis Group hf.

-- Alcon

-- AstraZeneca UK Ltd.

-- Bauch & Lomb

-- Baxter

-- Bayer

-- Beaufour Ipsen International

-- BELUPO

-- Beres

-- Berlin-Chemie AG/Menarini Group

-- Bionorica

-- Biotest Pharma

-- Boehringer Ingelheim Pharma

-- Boots Healthcare International

-- Bristol-Myers Squibb

-- Covex

-- CSC

-- CTS Chemical Industries

-- Deutsche Homoopathie-Union DHU-Arzneimittel GmbH&Co. KG

-- Dr. Falk

-- Dr. Kade

-- Dr. Reddy's Laboratories Ltd.

-- Dr. Willmar Schwabe

-- EBEWE Pharma

-- Egis

-- Esparma GmbH

-- Ferring Pharmaceuticals B.V.

-- Ferrosan

-- Fresenius Kabi Deutschland GmbH

-- G. Pohl-Boskamp GmbH & Co. KG

-- Gedeon Richter

-- Gerot Pharmazeutika

-- GlaxoSmithKline

-- Glenmark Pharmaceuticals Ltd.

-- Grodziskie Zaklady Farmaceutyczne Polfa Sp. z o.o.

-- Grunenthal

-- Guerbet

-- Heel

-- Hemofarm

-- Hexal AG

-- ICN Pharmaceuticals Switzerland Ltd.

-- IVAX Pharmaceuticals s.r.o.

-- Janssen-Cilag

-- Jelfa S.A.

-- Krewel Meuselbach

-- KRKA

-- Laboratoire Innotech International

-- Laboratorios Bago

-- Lannacher Heilmittel

-- Lek

-- Lilly

-- M.G. Group

-- Medana Pharma TERPOL Group J.S., Co.

-- Merz Pharma GmbH & Co. KgaA

-- MSD

-- Mucos Pharma GmbH & Co.

-- Mundipharma

-- Nestle

-- Novartis

-- Novo Nordisk

-- Nycomed

-- Organon

-- Orion

-- Pabianickie Zaklady Farmaceutyczne Polfa S.A.

-- Pfizer

-- Pharma Riace Ltd.

-- Pierre Fabre Medicament

-- Pliva

-- PRO.MED.CS Praha a.s.

-- Ranbaxy

-- Ratiopharm GmbH

-- Roche

-- SANOFI AVENTIS

-- Santen OY

-- Schering AG

-- Schering-Plough

-- Schwarz Pharma

-- Servier

-- Solvay

-- Stada Arzneimittel AG

-- Torrent Pharmaceuticals

-- UCB S.A. Pharma Sector

-- Unipharm, Inc.

-- Ursapharm Arzneimittel

-- Vifor (International) Inc.

-- Warszawskie Zaklady Farmaceutyczne Polfa S.A.

-- Worwag Pharma GmbH & Co. KG

-- Yamanouchi

-- Zambon Group

-- Zentiva a.s.

For more information visit http://www.researchandmarkets.com/reports/c20499.

Source: Business Wire

More News in this Category